News about Drug Discovery & Development

China Approves Azstarys for ADHD Treatment

ArkBio secures NMPA nod for once-daily ADHD treatment in China.

Drug Discovery & Development | 06/01/2026 | By News Bureau |  383

Semaglutide Patent Expiry to Open Over USD 600 Million Opportunity for Generic Drugmakers

Industry estimates suggest that around 10 to 15 domestic and global drugmakers are likely to compete for this opportunity. In India, the introduction of generic semaglutide formulations, expected during the 2026–27 financial year, could generate incremental revenues of approximately USD 12–24 million within the branded formulations market.

Drug Discovery & Development | 06/01/2026 | By Darshana |  307

FDA Clears BrainSpace's Intellidrop for Automated, Closed-Loop Brain Fluid Management

BrainSpace, a medical technology company developing automated solutions for neurological injury, disease and degeneration, has received US Food and Drug Administration (FDA) 510(k) clearance for Intellidrop, its automated brain fluid management system.

Drug Discovery & Development | 05/01/2026 | By Darshana |  361

Elanco Secures USDA Approval for Befrena mAb, Strengthening Canine Dermatology Portfolio

Elanco Animal Health Incorporated has received approval from the US Department of Agriculture (USDA) for Befrena (tirnovetmab), marking the company’s entry into the fast-growing canine dermatology segment with an anti-IL-31 monoclonal antibody therapy for allergic and atopic dermatitis in dogs.

Drug Discovery & Development | 03/01/2026 | By Darshana |  286

CARsgen Advances Allogeneic CAR-T Manufacturing with Dual IND Filings

CARsgen Therapeutics Holdings Limited announced that it has submitted two separate Investigational New Drug (IND) applications to China’s National Medical Products Administration for its allogeneic BCMA-targeted CAR T-cell therapy, CT0596.

Drug Discovery & Development | 30/12/2025 | By Darshana

Nona Biosciences Expands Discovery-to-Clinical Capabilities

Nona Biosciences has strengthened its integrated discovery-to-clinical framework by expanding proprietary platform technologies and enhancing preclinical and early clinical development capabilities, including CMC development, toxicology and clinical operations.

Drug Discovery & Development | 24/12/2025 | By News Bureau |  108

PM Narendra Modi Addresses Closing Ceremony of 2nd WHO Global Summit on Traditional Medicine

Addressing the closing ceremony of the Second WHO Global Summit on Traditional Medicine, Prime Minister Narendra Modi highlighted India’s leadership in traditional healthcare, the global impact of yoga and the establishment of key WHO institutions in Jamnagar and Delhi

Drug Discovery & Development | 20/12/2025 | By News Bureau |  133

Alembic Pharma Gets USFDA Nod for Ophthalmic Suspension With CGT Manufacturing Advantage

The product has been granted Competitive Generic Therapy (CGT) designation, making Alembic eligible for 180 days of market exclusivity in the USA once the product is launched. This exclusivity period provides a significant commercial advantage by limiting competition during initial marketing.

Drug Discovery & Development | 12/12/2025 | By Darshana |  192

MMV Joins iiCON to Boost Infectious Disease Drug Research and Manufacturing Innovation

iiCON, led by the Liverpool School of Tropical Medicine (LSTM), is a global infectious disease R&D programme that unites industry, academic institutions, and clinical bodies to accelerate the development of treatments, diagnostics, and prevention technologies for infectious diseases. Its mission is to save and improve lives.

Drug Discovery & Development | 11/12/2025 | By Darshana |  137

India Broadens Vaccine Partnership as BIRAC - CEPI Deal Extended to mAb Research

The Union Cabinet has approved the renewal and expansion of the strategic partnership between the Biotechnology Industry Research Assistance Council (BIRAC) and the Coalition for Epidemic Preparedness Innovations (CEPI).

Drug Discovery & Development | 07/12/2025 | By Darshana |  149